Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment [13]

Annals of the Rheumatic Diseases

Volumn 62, Issue 7, 2003, Pages 694-695

  Lazzerini, P E ^a   Capecchi, P L ^a   Bisogno, S ^b   Galeazzi, M ^b   Marcolongo, R ^b   Laghi Pasini, F ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETAINE; C REACTIVE PROTEIN; CORTICOSTEROID; CREATININE; CYANOCOBALAMIN; FOLIC ACID; GLUCOCORTICOID; HOMOCYSTEINE; METHOTREXATE; METHYLPREDNISOLONE; METHYLTRANSFERASE; PYRIDOXINE; SALAZOSULFAPYRIDINE; STEROID;

ADULT; AGED; BOLUS INJECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DRUG MECHANISM; DRUG PULSE THERAPY; ENZYME ACTIVITY; FEMALE; FOLIC ACID BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LABORATORY TEST; LETTER; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RHEUMATOID ARTHRITIS; VITAMIN BLOOD LEVEL;

ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; GLUCOCORTICOIDS; HOMOCYSTEINE; HUMANS; METHYLPREDNISOLONE; PULSE THERAPY, DRUG; TREATMENT OUTCOME;

EID: 0037532658     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.62.7.694     Document Type: Letter

References (10)

1. Krogh Jensen M, Ekelund S, Svendsen L. Folate and homocysteine status and haemolysis in patients treated with sulphasalazine for arthritis. Scand J Clin Lab Invest 1996;56:421-9.
2. Roubenoff R, Dellaripa P, Nadeau MR, Abad LW, Muldoon BA, Selhub J, et al. Abnormal homocysteine metabolism in rheumatoid arthritis. Arthritis Rheum 1997;40:718-22.
3. Haagsma CJ, Blom HJ, van Riel PL, van't Hof MA, Giesendorf BA, van Oppenraaij-Emmerzaal D, et al. Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Ann Rheum Dis 1999;58:79-84.
4. Landewe RB, van den Borne BE, Beedveld FC, Dijkmans BA. Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity. Lancet 2000;355:1616-17.
5. Erb N, Kitas GD. Homocysteine modulation as a reason for continuous folic acid supplementation in methotrexate-treated rheumatoid arthritis patients. Rheumatology (Oxford) 2001;40:715-16.
6. Roubenoff R, Roubenoff RA, Selhub J, Nadeau MR, Cannon JG, Freeman LM, et al. Abnormal vitamin B6 status in rheumatoid cachexia: association with spontaneous tumor necrosis factor alpha production and markers of inflammation. Arthritis Rheum 1995;38:105-9.
7. Rall LC, Meydani SN. Vitamin B6 and immune competence. Nutr Rev 1993;51:217-25.
8. McCarty MF. Increased homocyst(e)ine associated with smoking, chronic inflammation, and aging may reflect acute-phase induction of pyridoxal phosphatase activity. Med Hypoth 2000;55:289-93.
9. Kim MH, Kim E, Passen EL, Meyer J, Kang SS. Cortisol and estradiol: nongenetic factors for hyperhomocyst(e)inemia. Metabolism 1997;46:247-9.
10. Mudd SH, Levy HL, Skovby F. Disorders of transulfuration. In: Scriver CR, Baudet AL, Sly WS, et al, eds. The metabolic and mol